Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Increased EGFR gene variations may predict chemotherapy outcomes in small cell lung cancer patients.

Skin cancer in sun-exposed areas is more likely to come back.

5α-reductase inhibitors do not improve survival in oesophageal and gastric cancer patients.

Ankylosing spondylitis does not increase the risk of hair loss.

Hypothyroidism may increase the risk of nonmelanoma skin cancer.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Ethnicity affects how polycystic ovary syndrome shows up in women, with white women having higher metabolic risks but less diabetes, and South Asian women showing more androgenic symptoms and being younger at presentation.

PRP is a simple, effective, and safe treatment for hair loss.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

PCOS may be linked to spina bifida in young females.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

GLP-1 RA medications may be linked to hair loss.

Diode laser hair removal is effective and safe, but side effects vary by ethnicity and treatment number.

Type 2 diabetes may increase the risk of severe hair loss in African American women.

The Korean study confirmed that bariatric surgery is effective for weight loss in Asians.

Women with PCOS often try to lose weight and see themselves as overweight, regardless of their actual BMI.

Women with alopecia may have a higher chance of getting thyroid cancer.

Autologous cellular micrografts improve hair density and thickness in the short term for androgenetic alopecia.

Non-hospitalized COVID-19 patients often have lingering symptoms for at least 30 days.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

Finasteride does not increase the risk of depression or suicide.

Endoscopic-assisted surgery leads to higher patient satisfaction in breast reconstruction.

The study has limitations, and future research should use better methods to improve treatment for children with hair loss.

People with androgenetic alopecia may have a higher risk of peripheral venous disorders.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Timely treatments like PRP, topical, and drugs can effectively reduce hair loss.

COVID-19 can cause hair loss due to stress, with inflammation markers like D-dimer levels playing a role.